Wickström, Malin

Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. [electronic resource] - Nature communications Nov 2015 - 8904 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2041-1723

10.1038/ncomms9904 doi


Animals
Antineoplastic Agents--pharmacology
Benzeneacetamides--pharmacology
Brain Neoplasms--drug therapy
Camptothecin--analogs & derivatives
Celecoxib--pharmacology
Cisplatin--pharmacology
Colorectal Neoplasms--drug therapy
DNA Modification Methylases--genetics
DNA Repair Enzymes--genetics
Dacarbazine--analogs & derivatives
Doxorubicin--pharmacology
Drug Resistance, Neoplasm--genetics
Flow Cytometry
Gene Expression Profiling
Gene Expression Regulation, Neoplastic--drug effects
Glioma--drug therapy
Glucose-6-Phosphate Isomerase
Heterocyclic Compounds, 3-Ring--pharmacology
Humans
Immunoblotting
Immunohistochemistry
Irinotecan
Medulloblastoma--drug therapy
Mice
Neoplasm Transplantation
Neoplasms--drug therapy
Neuroblastoma--drug therapy
Pyrans--pharmacology
Pyrazines--pharmacology
Pyridines--pharmacology
Real-Time Polymerase Chain Reaction
Sulfones--pharmacology
Temozolomide
Triazoles--pharmacology
Tumor Suppressor Proteins--genetics
Vincristine--pharmacology
Wnt Proteins--genetics
Wnt Signaling Pathway--drug effects
beta Catenin--genetics